6th Street Advisors LLC Acquires New Shares in Danaher Corporation $DHR

Key Points

• 6th Street Advisors acquired 5,848 Danaher shares worth approximately $1.3 million, while institutional investors collectively own 79.05% of the company.
• Analysts maintain a positive outlook, with Danaher receiving a consensus “Moderate Buy” rating and an average price target of $235.41.
• Danaher recently beat quarterly earnings and revenue estimates, while its collaboration with NVIDIA on autonomous science and AI-powered laboratories could support future growth.

6th Street Advisors LLC acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 5,848 shares of the conglomerate's stock, valued at approximately $1,296,000. Danaher accounts for approximately 0.7% of 6th Street Advisors LLC's portfolio, making the stock its 16th largest holding.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. BlackRock Inc. bought a new position in shares of Danaher during the second quarter valued at approximately $10,492,520,000. Wellington Management Group LLP grew its stake in Danaher by 10.4% in the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate's stock worth $3,108,031,000 after purchasing an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC purchased a new position in Danaher during the 2nd quarter worth $1,456,317,000. Generation Investment Management LLP purchased a new stake in shares of Danaher in the 2nd quarter worth $1,287,949,000. Finally, Bank of America Corp DE bought a new position in shares of Danaher during the 2nd quarter worth $993,846,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a report on Saturday. Stifel Nicolaus decreased their price target on shares of Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Evercore restated an "outperform" rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. TD Cowen upped their target price on Danaher from $236.00 to $255.00 and gave the company a "buy" rating in a research report on Tuesday. Finally, The Goldman Sachs Group increased their price objective on shares of Danaher from $210.00 to $250.00 and gave the company a "buy" rating in a research report on Monday, September 21st. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $235.41.

Key Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher and NVIDIA announced a collaboration combining Danaher’s scientific instruments, laboratory workflows, automation technologies and data with NVIDIA’s accelerated computing and AI capabilities. The companies aim to advance autonomous science and speed up research, potentially creating new growth opportunities in life-science tools. Danaher Collaborates with NVIDIA to Advance Autonomous Science
• Positive Sentiment: Danaher is reportedly preparing to launch its first AI-powered autonomous laboratory, expected to operate at commercial scale in early 2027. The initiative could support demand for Danaher’s instruments, software and laboratory automation offerings as AI adoption expands. How to Invest in AI Drug Discovery
• Positive Sentiment: Zacks said Danaher has two indicators associated with a potential earnings beat ahead of its upcoming report. A stronger-than-expected result could reinforce investor confidence following the company’s previous quarterly beat on revenue and earnings. Danaher Earnings Expected to Grow
• Positive Sentiment: Morgan Stanley maintained its $240 price target for DHR, signaling continued confidence in the stock’s outlook and leaving room for further appreciation based on the referenced trading level. Morgan Stanley Keeps $240 Target for Danaher
• Neutral Sentiment: Danaher appointed Daniel L. Comas and Robert Hershberg to its board, expanding it to 13 members. The appointments may strengthen governance and industry expertise but are unlikely to materially affect near-term trading. Danaher Announces Board Appointments

Danaher Price Performance

Shares of NYSE:DHR traded up $1.19 during midday trading on Wednesday, reaching $224.03. 1,890,805 shares of the company's stock traded hands, compared to its average volume of 4,448,106. The company has a fifty day simple moving average of $212.41 and a two-hundred day simple moving average of $195.13. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a market cap of $157.49 billion, a P/E ratio of 39.79, a PEG ratio of 2.78 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher's quarterly revenue was up 5.5% compared to the same quarter last year. During the same period last year, the company posted $0.77 EPS. Equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher's payout ratio is presently 28.42%.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.